Literature DB >> 12298117

Accuracy and precision of the Cholestech LDX System in monitoring blood lipid levels.

Jennifer Santee1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12298117     DOI： 10.1093/ajhp/59.18.1774

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  11 in total

1.  Rationale, design, and baseline characteristics of a community-based comparative effectiveness trial to prevent type 2 diabetes in economically disadvantaged adults: the RAPID Study.

Authors:  Ronald T Ackermann; Emily A Finch; Karen K Schmidt; Helena M Hoen; Laura M Hays; David G Marrero; Chandan Saha
Journal:  Contemp Clin Trials       Date:  2013-10-29       Impact factor: 2.226

2.  Mediators of the relationship between socioeconomic status and allostatic load in the Chicago Health, Aging, and Social Relations Study (CHASRS).

Authors:  Louise C Hawkley; Leah A Lavelle; Gary G Berntson; John T Cacioppo
Journal:  Psychophysiology       Date:  2011-02-22       Impact factor: 4.016

3.  One-year effects of a group-based lifestyle intervention in adults with type 2 diabetes: A randomized encouragement trial.

Authors:  David T Liss; Emily A Finch; Andrew Cooper; Avani Sheth; Ashantí D Tejuosho; Nicola Lancki; Ronald T Ackermann
Journal:  Diabetes Res Clin Pract       Date:  2018-03-27       Impact factor: 5.602

4.  A Randomized Comparative Effectiveness Trial for Preventing Type 2 Diabetes.

Authors:  Ronald T Ackermann; David T Liss; Emily A Finch; Karen K Schmidt; Laura M Hays; David G Marrero; Chandan Saha
Journal:  Am J Public Health       Date:  2015-09-17       Impact factor: 9.308

5.  Physical Activity for Campus Employees: A University Worksite Wellness Program.

Authors:  Carling E Butler; B Ruth Clark; Tamara L Burlis; Jacqueline C Castillo; Susan B Racette
Journal:  J Phys Act Health       Date:  2014-06-04

6.  Design and participant characteristics for a randomized effectiveness trial of an intensive lifestyle intervention to reduce cardiovascular risk in adults with type 2 diabetes: The I-D-HEALTH study.

Authors:  David T Liss; Emily A Finch; Dyanna L Gregory; Andrew Cooper; Ronald T Ackermann
Journal:  Contemp Clin Trials       Date:  2015-12-02       Impact factor: 2.226

7.  Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study.

Authors:  Kevin P Mc Namara; Johnson George; Sharleen L O'Reilly; Shane L Jackson; Gregory M Peterson; Helen Howarth; Michael J Bailey; Gregory Duncan; Peta Trinder; Elizabeth Morabito; Jill Finch; Stephen Bunker; Edward Janus; Jon Emery; James A Dunbar
Journal:  BMC Health Serv Res       Date:  2010-09-07       Impact factor: 2.655

8.  Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study.

Authors:  Ronald T Ackermann; Emily A Finch; Edward Brizendine; Honghong Zhou; David G Marrero
Journal:  Am J Prev Med       Date:  2008-10       Impact factor: 5.043

9.  Reduced 10-year risk of coronary heart disease in patients who participated in a community-based diabetes prevention program: the DEPLOY pilot study.

Authors:  Elaine R Lipscomb; Emily A Finch; Edward Brizendine; Chandan K Saha; Laura M Hays; Ronald T Ackermann
Journal:  Diabetes Care       Date:  2008-12-23       Impact factor: 19.112

10.  Assessing cardiovascular risk in regional areas: the Healthy Hearts Beyond City Limits program.

Authors:  Melinda J Carrington; Garry L Jennings; Robyn A Clark; Simon Stewart
Journal:  BMC Health Serv Res       Date:  2012-09-03       Impact factor: 2.655
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.